Indo Borax & Chemicals Ltd
NSE: INDOBORAX BSE: 524342
Incorporated in 1980, Indo Borax & Chemicals Ltd is in the business of manufacturing Boron and Lithium products[1]
₹273
52W: ₹177 — ₹302
PE 22.7 · Book ₹112 · +144% vs bookMarket Cap₹877 Cr
Stock P/E22.7Price to Earnings
ROCE18.1%Return on Capital
ROE13.1%Return on Equity
Div. Yield0.37%Face Value ₹1
Strengths
- +Company is almost debt free.
Weaknesses
- −Promoter holding has decreased over last quarter: -20.0%
- −The company has delivered a poor sales growth of 8.74% over past five years.
- −Promoter holding is low: 30.8%
- −Promoters have pledged 100% of their holding.
- −Earnings include an other income of Rs.23.1 Cr.
- −Dividend payout has been low at 7.46% of profits over last 3 years
Shareholding Pattern
Promoters30.8%
FIIs0.45%
DIIs2.19%
Public66.56%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 50.79% | 50.79% | 50.79% | 50.79% | 50.79% | 50.79% | 50.79% | 30.8%▼20.0 |
| FIIs | 0% | 0.06%▲0.1 | 0.01%▼0.0 | 0.02%▲0.0 | 0.02% | 0.53%▲0.5 | 0.23%▼0.3 | 0.45%▲0.2 |
| DIIs | 0.06% | 0%▼0.1 | 0% | 0.01%▲0.0 | 0.02%▲0.0 | 0.02% | 0.02% | 2.19%▲2.2 |
| Public | 49.15% | 49.14%▼0.0 | 49.2%▲0.1 | 49.16%▼0.0 | 49.16% | 48.67%▼0.5 | 48.96%▲0.3 | 66.56%▲17.6 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 46.8 | 44.06 | 45.46 | 49.76 | 37.87 | 37.51 | 50.12 | 53.57 | 57.85 | 41.02 |
| Expenses | 36.64 | 34.88 | 33.89 | 33.31 | 28.71 | 27.44 | 39.92 | 41.36 | 47.35 | 32.39 |
| Operating Profit | 10.16 | 9.18 | 11.57 | 16.45 | 9.16 | 10.07 | 10.2 | 12.21 | 10.5 | 8.63 |
| OPM % | 21.71% | 20.84% | 25.45% | 33.06% | 24.19% | 26.85% | 20.35% | 22.79% | 18.15% | 21.04% |
| Net Profit | 8.79 | 8.08 | 11.29 | 13.86 | 9.03 | 8.92 | 10.07 | 10.04 | 16.09 | 9.11 |
| EPS ₹ | 2.74 | 2.52 | 3.52 | 4.32 | 2.81 | 2.78 | 3.14 | 3.13 | 5.01 | 2.84 |
AI Insights
Revenue Trend
TTM revenue at ₹203Cr, up 16% YoY. OPM at 21%.
Debt Position
Borrowings at ₹0Cr. Debt-to-equity ratio: 0.00x. Healthy balance sheet.
Capex Cycle
CWIP at ₹1Cr (1% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 2.19% (+2.19pp change). FIIs: 0.45% (+0.23pp change). Promoters hold 30.8%.
Margin & Efficiency
ROCE declining from 23% (Mar 2014) to 18% (Mar 2025). Working capital days: 111.
Valuation
PE 22.7x with 18.1% ROCE. Price is 144% above book value of ₹112. Dividend yield: 0.37%.
Recent Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 15 May
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 13 May
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 11 May
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 5 May
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 5 May
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse